Best Fit Profiles
- experimental mitochondrial stacks
Mitochondrial biogenesis support
PQQ (Pyrroloquinoline Quinone)
Early human studies suggest support for fatigue and mitochondrial-related endpoints, but larger confirmatory trials are still needed.
Evidence Level C
Evidence and Risk Labels
Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.
See full scoring guideClinical Snapshot
- Effect Size
- Modest fatigue and mitochondrial-support signal
- Safety
- Moderate Risk
Human data depth is still limited and should be interpreted conservatively.
Research Dosing
This reflects common ranges and protocols used in published studies, not personal medical advice.
- Typical Daily Dose
- 10-20 mg
- Timing
- Morning with food
- Protocol Duration in Studies
- 4-12 weeks in preliminary studies
Often stacked with CoQ10 in exploratory protocols.